Cargando…

Phenotypic Evaluation of Nucleoside Analogues against Trypanosoma cruzi Infection: In Vitro and In Vivo Approaches

Chagas disease, caused by Trypanosoma cruzi (T. cruzi), is a serious public health problem. Current treatment is restricted to two drugs, benznidazole and nifurtimox, displaying serious efficacy and safety drawbacks. Nucleoside analogues represent a promising alternative as protozoans do not biosynt...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fiuza, Ludmila F. de A., Batista, Denise G. J., Girão, Roberson D., Hulpia, Fabian, Finamore-Araújo, Paula, Aldfer, Mustafa M., Elmahallawy, Ehab Kotb, De Koning, Harry P., Moreira, Otacílio, Van Calenbergh, Serge, Soeiro, Maria de Nazaré C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9695592/ https://www.ncbi.nlm.nih.gov/pubmed/36432189 http://dx.doi.org/10.3390/molecules27228087

Ejemplares similares

The Trypanosoma cruzi TcrNT2 Nucleoside Transporter Is a Conduit for the Uptake of 5-F-2′-Deoxyuridine and Tubercidin Analogues
por: Aldfer, Mustafa M., et al.
Publicado: (2022)

Nucleoside analogues for the treatment of animal trypanosomiasis
por: Mabille, Dorien, et al.
Publicado: (2022)

Nucleoside triphosphate diphosphohydrolase1 (TcNTPDase-1) gene expression is increased due to heat shock and in infective forms of Trypanosoma cruzi
por: Silva-Gomes, Natália Lins, et al.
Publicado: (2014)

Combined Treatment of Heterocyclic Analogues and Benznidazole upon Trypanosoma cruzi In Vivo
por: Batista, Denise da Gama Jaén, et al.
Publicado: (2011)

In vitro and in silico analysis of imatinib analogues as anti-Trypanosoma cruzi drug candidates
por: Nesic de Freitas, Luca S. F., et al.
Publicado: (2023)

4E Interacting Protein as a Potential Novel Drug Target for Nucleoside Analogues in Trypanosoma brucei
por: Mabille, Dorien, et al.
Publicado: (2021)

6-Methyl-7-deazapurine nucleoside analogues as broad-spectrum antikinetoplastid agents
por: Lin, Cai, et al.
Publicado: (2021)

7-Aryl-7-deazapurine 3′-deoxyribonucleoside derivative as a novel lead for Chagas’ disease therapy: in vitro and in vivo pharmacology
por: Cardoso-Santos, Camila, et al.
Publicado: (2021)

Combination With Tomatidine Improves the Potency of Posaconazole Against Trypanosoma cruzi
por: Rocha-Hasler, Marianne, et al.
Publicado: (2021)

Screening of Potential anti-Trypanosoma cruzi Candidates: In Vitro and In Vivo Studies
por: Soeiro, Maria de Nazaré C, et al.
Publicado: (2011)

Overexpression of TcNTPDase-1 Gene Increases Infectivity in Mice Infected with Trypanosoma cruzi
por: da Silva-Gomes, Natália Lins, et al.
Publicado: (2022)

The Impact of the CTHRSSVVC Peptide Upon Experimental Models of Trypanosoma cruzi Infection
por: Leite, Gabriela Rodrigues, et al.
Publicado: (2022)

Cloning and Characterization of Trypanosoma congolense and T. vivax Nucleoside Transporters Reveal the Potential of P1-Type Carriers for the Discovery of Broad-Spectrum Nucleoside-Based Therapeutics against Animal African Trypanosomiasis
por: Ungogo, Marzuq A., et al.
Publicado: (2023)

In Vitro Phenotypic Activity and In Silico Analysis of Natural Products from Brazilian Biodiversity on Trypanosoma cruzi
por: Peres, Raiza B., et al.
Publicado: (2021)

Antiparasitic Activity of Plumbago auriculata Extracts and Its Naphthoquinone Plumbagin against Trypanosoma cruzi
por: Peres, Raiza Brandão, et al.
Publicado: (2023)

Investigation of pyrimidine nucleoside analogues as chemical probes to assess compound effects on the proliferation of Trypanosoma cruzi intracellular parasites
por: Sykes, Melissa Louise, et al.
Publicado: (2020)

RNA as a feasible marker of Trypanosoma cruzi viability during the parasite interaction with the triatomine vector Rhodnius prolixus (Hemiptera, Triatominae)
por: Finamore-Araujo, Paula, et al.
Publicado: (2022)

Electrocardiographic Findings in Acutely and Chronically T. cruzi-infected Mice Treated by a Phenyl-Substituted Analogue of Furamidine DB569
por: de Souza, Elen M., et al.
Publicado: (2007)

Influence of Ecto-Nucleoside Triphosphate Diphosphohydrolase Activity on Trypanosoma cruzi Infectivity and Virulence
por: Santos, Ramon F., et al.
Publicado: (2009)

Identification of Phenylpyrazolone Dimers as a New Class of Anti‐Trypanosoma cruzi Agents
por: Sijm, Maarten, et al.
Publicado: (2019)

Efficacy of sertraline against Trypanosoma cruzi: an in vitro and in silico study
por: Ferreira, Daiane Dias, et al.
Publicado: (2018)

Validation of a novel multiplex real-time PCR assay for Trypanosoma cruzi detection and quantification in açai pulp
por: Finamore-Araujo, Paula, et al.
Publicado: (2021)

Activity of Estafietin and Analogues on Trypanosoma cruzi and Leishmania braziliensis
por: Sülsen, Valeria P., et al.
Publicado: (2019)

Exploring the purine core of 3′-C-ethynyladenosine (EAdo) in search of novel nucleoside therapeutics
por: Hulpia, Fabian, et al.
Publicado: (2016)

Norfloxacin and N-Donor Mixed-Ligand Copper(II) Complexes: Synthesis, Albumin Interaction, and Anti-Trypanosoma cruzi Activity
por: Martins, Darliane A., et al.
Publicado: (2016)

Synthesis of a 3′-C-ethynyl-β-d-ribofuranose purine nucleoside library: Discovery of C7-deazapurine analogs as potent antiproliferative nucleosides
por: Hulpia, Fabian, et al.
Publicado: (2018)

Experimental Chemotherapy for Chagas Disease: A Morphological, Biochemical, and Proteomic Overview of Potential Trypanosoma cruzi Targets of Amidines Derivatives and Naphthoquinones
por: de Castro, Solange L., et al.
Publicado: (2011)

Role of Trypanosoma cruzi nucleoside diphosphate kinase 1 in DNA damage responses
por: Reigada, Chantal, et al.
Publicado: (2020)

Impact of autologous whole blood administration upon experimental mouse models of acute Trypanosoma cruzi infection
por: Philot Pavão, Beatriz, et al.
Publicado: (2018)

Phenotypic evaluation and in silico ADMET properties of novel arylimidamides in acute mouse models of Trypanosoma cruzi infection
por: da Silva, Cristiane França, et al.
Publicado: (2017)

A Toxoplasma gondii Oxopurine Transporter Binds Nucleobases and Nucleosides Using Different Binding Modes
por: Campagnaro, Gustavo D., et al.
Publicado: (2022)

Identification of compounds with activity against Trypanosoma cruzi within a collection of synthetic nucleoside analogs
por: Barnadas-Carceller, Berta, et al.
Publicado: (2023)

Detection and genotyping of Trypanosoma cruzi from açai products commercialized in Rio de Janeiro and Pará, Brazil
por: Ferreira, Renata Trotta Barroso, et al.
Publicado: (2018)

Nucleoside analogue activators of cyclic AMP-independent protein kinase A of Trypanosoma
por: Bachmaier, Sabine, et al.
Publicado: (2019)

Increased angiogenesis parallels cardiac tissue remodelling in experimental acute Trypanosoma cruzi infection
por: Nisimura, Lindice Mitie, et al.
Publicado: (2022)

Clathrin expression in Trypanosoma cruzi
por: Kalb, Ligia Cristina, et al.
Publicado: (2014)

Trypanosoma cruzi mitochondrial swelling and membrane potential collapse as primary evidence of the mode of action of naphthoquinone analogues
por: Salomão, Kelly, et al.
Publicado: (2013)

Glutamine Analogues Impair Cell Proliferation, the Intracellular Cycle and Metacyclogenesis in Trypanosoma cruzi
por: Souza, Rodolpho Ornitz Oliveira, et al.
Publicado: (2020)

Development of conventional and real-time multiplex PCR-based assays for estimation of natural infection rates and Trypanosoma cruzi load in triatomine vectors
por: Moreira, Otacilio C., et al.
Publicado: (2017)

Trypanosoma cruzi–Host Cell Interaction
por: De Souza, Wanderley
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_rc1nsc2u5dml7khkvei9v07u0q